Related Experiment Video
Updated: Feb 8, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
Delivering Phage Products to Combat Antibiotic Resistance in Developing Countries: Lessons Learned from the HIV/AIDS
1Phages for Global Health, 383 62nd Street, Oakland, CA 94618, USA. tobi@phagesforglobalhealth.org.
Abstract:
The antimicrobial resistance (AMR) crisis and HIV/AIDS epidemic exhibit many parallels. In both, infectious diseases have caused millions of deaths worldwide, with AMR expected to kill even more people each year than HIV/AIDS did at its peak. In addition, both have required or will require new classes of drugs for control. For HIV/AIDS, development of vital antiretroviral drugs (ARVs) was accomplished in several stages: expanding public awareness about the disease, gathering commitment from the international community to tackle the problem, and eventually establishing policies and global funds to deliver new therapeutics. For AMR, the pursuit of new antimicrobials appears to be following a similar trajectory. This paper examines how lessons and processes leading to ARVs might be applied to developing AMR drugs, in particular bacteriophages (phages). These possess many essential characteristics: inexpensive manufacture, rapid drug development, and a ready means to prevent phage-resistant microbes from emerging. However, the broad application of phage-based products has yet to be fully demonstrated, and will require both international coordination and modified regulatory policies.
Insights
Lessons from the HIV/AIDS epidemic, including developing antiretroviral drugs (ARVs), can guide the fight against antimicrobial resistance (AMR). Bacteriophages (phages) show promise as a new AMR therapeutic, but require global coordination and policy changes.
Area of Science:
- Microbiology
- Epidemiology
- Drug Development
Background:
- The antimicrobial resistance (AMR) crisis poses a significant global health threat, comparable to the historical impact of HIV/AIDS.
- Both AMR and HIV/AIDS necessitate the development of novel therapeutic agents for effective disease control.
Purpose of the Study:
- To examine parallels between the HIV/AIDS epidemic and the AMR crisis.
- To explore how lessons learned from the development of antiretroviral drugs (ARVs) can inform the development of new antimicrobial therapies, specifically bacteriophages (phages).
Main Methods:
- Comparative analysis of historical approaches to HIV/AIDS drug development.
- Evaluation of bacteriophages (phages) as potential antimicrobial agents based on their characteristics and development trajectory.
- Review of necessary international coordination and regulatory policy modifications.
Main Results:
- Antimicrobial resistance (AMR) is projected to cause more deaths annually than HIV/AIDS did at its peak.
- Bacteriophages (phages) offer advantages such as inexpensive manufacturing, rapid development, and inherent mechanisms to prevent resistance.
- The development pathway for phage-based antimicrobials mirrors key stages observed in the progression of antiretroviral drugs (ARVs).
Conclusions:
- Applying strategies from the antiretroviral drugs (ARVs) development to antimicrobial resistance (AMR) is a viable approach.
- Bacteriophages (phages) represent a promising therapeutic avenue for combating antimicrobial resistance (AMR).
- Successful broad application of phage-based therapies necessitates international collaboration and adaptive regulatory frameworks.
Related Concept Videos
Development of Antibiotic Resistance
Antibiotic Selection
Resistivity
Resistance
Avoidance Learning and Learned Helplessness
Avoidance learning occurs when an organism learns that a specific behavior can prevent an unpleasant outcome. For example, a student who receives a bad grade may start studying harder to avoid future poor grades. This behavior persists even when the negative outcome is no longer present. Avoidance learning is powerful because it maintains behavior in the absence of the...
Fruit Development, Structure, and Function

